Copyright Reports & Markets. All rights reserved.

Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Report 2021

Request for Sample of this report
Buy now

1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Overview

  • 1.1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Scope
  • 1.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Segment by Type
    • 1.2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Serum Biomarkers
    • 1.2.3 Cytokeratin-18 (CK 18) Marker
    • 1.2.4 Inflammatory Markers
    • 1.2.5 Others
  • 1.3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Segment by Application
    • 1.3.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Hospitals
    • 1.3.3 Diagnostic Centers
    • 1.3.4 Others
  • 1.4 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price Trends (2016-2027)

2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Estimates and Forecasts by Region

  • 2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Region (2016-2021)
  • 2.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Estimates and Projections (2016-2027)
    • 2.4.2 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Estimates and Projections (2016-2027)
    • 2.4.3 China Non-alcoholic Steatohepatitis (NASH) Biomarkers Estimates and Projections (2016-2027)
    • 2.4.4 Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Estimates and Projections (2016-2027)
    • 2.4.6 India Non-alcoholic Steatohepatitis (NASH) Biomarkers Estimates and Projections (2016-2027)

3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Competition Landscape by Players

  • 3.1 Global Top Non-alcoholic Steatohepatitis (NASH) Biomarkers Players by Sales (2016-2021)
  • 3.2 Global Top Non-alcoholic Steatohepatitis (NASH) Biomarkers Players by Revenue (2016-2021)
  • 3.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Non-alcoholic Steatohepatitis (NASH) Biomarkers as of 2020)
  • 3.4 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Average Price by Company (2016-2021)
  • 3.5 Manufacturers Non-alcoholic Steatohepatitis (NASH) Biomarkers Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Type

  • 4.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price by Type (2016-2021)
  • 4.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price Forecast by Type (2022-2027)

5 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Application

  • 5.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price by Application (2016-2021)
  • 5.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price Forecast by Application (2022-2027)

6 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures

  • 6.1 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company
    • 6.1.1 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company (2016-2021)
    • 6.1.2 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Company (2016-2021)
  • 6.2 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type
    • 6.2.1 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type (2022-2027)
  • 6.3 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Application
    • 6.3.1 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Application (2022-2027)

7 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures

  • 7.1 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company
    • 7.1.1 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company (2016-2021)
    • 7.1.2 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Company (2016-2021)
  • 7.2 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type
    • 7.2.1 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Application
    • 7.3.1 Europe 139 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 139 Sales Breakdown by Application (2022-2027)

8 China Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures

  • 8.1 China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company
    • 8.1.1 China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company (2016-2021)
    • 8.1.2 China Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Company (2016-2021)
  • 8.2 China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type
    • 8.2.1 China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type (2022-2027)
  • 8.3 China Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Application
    • 8.3.1 China 243 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 243 Sales Breakdown by Application (2022-2027)

9 Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures

  • 9.1 Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company
    • 9.1.1 Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company (2016-2021)
    • 9.1.2 Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Company (2016-2021)
  • 9.2 Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type
    • 9.2.1 Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures

  • 10.1 Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company
    • 10.1.1 Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type
    • 10.2.1 Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures

  • 11.1 India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company
    • 11.1.1 India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Company (2016-2021)
    • 11.1.2 India Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Company (2016-2021)
  • 11.2 India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type
    • 11.2.1 India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Type (2022-2027)
  • 11.3 India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Application
    • 11.3.1 India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Non-alcoholic Steatohepatitis (NASH) Biomarkers Business

  • 12.1 Biopredictive
    • 12.1.1 Biopredictive Corporation Information
    • 12.1.2 Biopredictive Business Overview
    • 12.1.3 Biopredictive Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Biopredictive Non-alcoholic Steatohepatitis (NASH) Biomarkers Products Offered
    • 12.1.5 Biopredictive Recent Development
  • 12.2 Quest Diagnostics
    • 12.2.1 Quest Diagnostics Corporation Information
    • 12.2.2 Quest Diagnostics Business Overview
    • 12.2.3 Quest Diagnostics Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Quest Diagnostics Non-alcoholic Steatohepatitis (NASH) Biomarkers Products Offered
    • 12.2.5 Quest Diagnostics Recent Development
  • 12.3 Exalenz Bioscience
    • 12.3.1 Exalenz Bioscience Corporation Information
    • 12.3.2 Exalenz Bioscience Business Overview
    • 12.3.3 Exalenz Bioscience Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Exalenz Bioscience Non-alcoholic Steatohepatitis (NASH) Biomarkers Products Offered
    • 12.3.5 Exalenz Bioscience Recent Development
  • 12.4 GENFIT
    • 12.4.1 GENFIT Corporation Information
    • 12.4.2 GENFIT Business Overview
    • 12.4.3 GENFIT Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 GENFIT Non-alcoholic Steatohepatitis (NASH) Biomarkers Products Offered
    • 12.4.5 GENFIT Recent Development
  • 12.5 Siemens Healthineers
    • 12.5.1 Siemens Healthineers Corporation Information
    • 12.5.2 Siemens Healthineers Business Overview
    • 12.5.3 Siemens Healthineers Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Siemens Healthineers Non-alcoholic Steatohepatitis (NASH) Biomarkers Products Offered
    • 12.5.5 Siemens Healthineers Recent Development
  • 12.6 ONE WAY LIVER
    • 12.6.1 ONE WAY LIVER Corporation Information
    • 12.6.2 ONE WAY LIVER Business Overview
    • 12.6.3 ONE WAY LIVER Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 ONE WAY LIVER Non-alcoholic Steatohepatitis (NASH) Biomarkers Products Offered
    • 12.6.5 ONE WAY LIVER Recent Development
  • 12.7 Prometheus Laboratories
    • 12.7.1 Prometheus Laboratories Corporation Information
    • 12.7.2 Prometheus Laboratories Business Overview
    • 12.7.3 Prometheus Laboratories Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Prometheus Laboratories Non-alcoholic Steatohepatitis (NASH) Biomarkers Products Offered
    • 12.7.5 Prometheus Laboratories Recent Development
  • 12.8 Gilead Sciences
    • 12.8.1 Gilead Sciences Corporation Information
    • 12.8.2 Gilead Sciences Business Overview
    • 12.8.3 Gilead Sciences Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Gilead Sciences Non-alcoholic Steatohepatitis (NASH) Biomarkers Products Offered
    • 12.8.5 Gilead Sciences Recent Development

13 Non-alcoholic Steatohepatitis (NASH) Biomarkers Manufacturing Cost Analysis

  • 13.1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Non-alcoholic Steatohepatitis (NASH) Biomarkers
  • 13.4 Non-alcoholic Steatohepatitis (NASH) Biomarkers Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Distributors List
  • 14.3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Customers

15 Market Dynamics

  • 15.1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Trends
  • 15.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Drivers
  • 15.3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Challenges
  • 15.4 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    The global Non-alcoholic Steatohepatitis (NASH) Biomarkers market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Non-alcoholic Steatohepatitis (NASH) Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

    Segment by Type
    Serum Biomarkers
    Cytokeratin-18 (CK 18) Marker
    Inflammatory Markers
    Others

    Segment by Application
    Hospitals
    Diagnostic Centers
    Others

    The Non-alcoholic Steatohepatitis (NASH) Biomarkers market is analysed and market size information is provided by regions (countries). Segment by Application, the Non-alcoholic Steatohepatitis (NASH) Biomarkers market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

    By Company
    Biopredictive
    Quest Diagnostics
    Exalenz Bioscience
    GENFIT
    Siemens Healthineers
    ONE WAY LIVER
    Prometheus Laboratories
    Gilead Sciences

    Buy now